I bought half the shares back I sold after the FDA CLR's. Seems like a bottom has been found and we should get a good understanding of the path to approval for a couple of indications soon. Might involve a bit more work, but important thing from investor point of view is the likelihood of approval should rise considerably. After the CLR's each approval depends on 'a change of heart', which is hard to link to future revenue.
I bought half the shares back I sold after the FDA CLR's. Seems...
-
- There are more pages in this discussion • 3,264 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $381.1K | 414.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 170161 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 41927 | 17 |
View Market Depth
| Last trade - 10.45am 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |